York Bridge Wealth Partners, LLC Biomarin Pharmaceutical Inc Transaction History

York Bridge Wealth Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 21, 2019	SELL	$67.4 - $85.11 $45,090 - $56,938	-669 Closed	0 $0
Q2 2019 Jul 18, 2019	BUY	$80.35 - $93.9 $4,258 - $4,976	53 Added 8.6%	669 $57,000
Q1 2019 May 09, 2019	BUY	$84.2 - $98.62 $842 - $986	10 Added 1.65%	616 $55,000
Q4 2018 Feb 14, 2019	BUY	$80.14 - $106.07 $21,076 - $27,896	263 Added 76.68%	606 $52,000
Q3 2018 Nov 14, 2018	BUY	$93.92 - $105.72 $2,066 - $2,325	22 Added 6.85%	343 $34,000
Q2 2018 Aug 10, 2018	BUY	$76.01 - $99.03 $24,399 - $31,788	321 New	321 $30,000

637

177M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of York Bridge Wealth Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on York Bridge Wealth Partners, LLC with notifications on news.